Medicines and Related Substances Control Amendment Act, 1997
| Medicines and Related Substance 1997 | |
|---|---|
| Government of South Africa | |
| Enacted by | Government of South Africa |
| Enacted | 1997 |
| Status: Current legislation | |
South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.
Enactment
In an effort to combat the growing HIV/AIDS epidemic, the Government of South Africa enacted the Medicines and Related Substances Control Amendment Act in 1997.[1][2] The Act aimed to both reduce the cost of drugs and increase their availability.[2]
Challenge to the Law
In February 1998, the South African Pharmaceutical Manufactures Association and forty
Agreement on Trade-Related Aspects of Intellectual Property Rights.[3][4] The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.[4]
In agreement with the suit, the United States (US) and
References
- ^ "MEDICINES AND RELATED SUBSTANCES CONTROL ACT 101 OF 1965" (PDF). Archived from the original (PDF) on 2012-01-05. Retrieved 2012-07-15., Medicines and Related Substances Control Amendment Act of 1997
- ^ a b Duane Nash, “South Africa's Medicines and Related Substances Control Amendment Act of 1997,” Berkeley Technology Law Journal 15 (2002): 485-504
- PMID 11222409.
- ^ PMID 15709298.
- ^ Mayne, Ruth (1 February 2001). "South Africa vs. the Drug Giants: A challenge to affordable medicines". Oxfam - Policy & Practice. Retrieved 24 May 2018.
- PMID 11325753.